Impact of Internet pharmacy regulation on opioid analgesic availability
- PMID: 18781245
- PMCID: PMC2575390
- DOI: 10.15288/jsad.2008.69.703
Impact of Internet pharmacy regulation on opioid analgesic availability
Abstract
Objective: Access to prescription opioid analgesics has made Internet pharmacies the object of increased regulatory scrutiny, but the effectiveness of regulatory changes in curtailing availability of opioid analgesics from online sources has been not assessed. As part of an ongoing investigation into the relationship between the Internet and substance abuse, we examined the availability of prescription opioid analgesics from online pharmacies.
Method: From a pharmacy watch Web site, we constructed a data set of postings entered every 3 months beginning November 1, 2005, that were related to the purchase of prescription opioid analgesics. Trained examiners assessed whether the final post described accessibility of pain medications that was increasing or decreasing.
Results: We identified 45 threads related to the availability of opioid analgesics from Internet pharmacies. Of the 41 (91%) threads describing the declining availability of opioid analgesic agents from Internet pharmacies, 34 (82%) received posts on November 1, 2007. Despite the subjective nature of the research question, there was high interobserver agreement between coders (kappa= .845) that availability of opioid analgesics from online pharmacies had decreased. This finding was supported by a dramatic rise in the number of pageviews (an accepted measure of Web site visitor interest in a page's content) of Web pages describing decreased availability of opioid analgesics.
Conclusions: These data suggest striking decreases in the availability of prescription opioid analgesic pharmaceuticals. This self-reported change in drug availability may be related to increased regulation of and law enforcement operations directed against Internet pharmacies.
Figures
References
-
- Boyer EW. Internet pharmacies and online opioid purchases; Invited talk presented at the annual meeting of the National Institute on Drug Abuse Community Epidemiology Work Group; January 18–20; Phoenix, AZ. 2006.
-
- Boyer EW, Babu KM, Macalino GE, Compton W. Self-treatment of opioid withdrawal with a dietary supplement, kratom. Amer. J. Addict. 2007;16:352–356. - PubMed
-
- Burby J, Atchison S. Actionable Web Analytics: Using Data to Make Smart Business Decisions. Hoboken, NJ: John Wiley & Sons; 2007.
-
- Committee On Energy and CommercePrepared Statement of the Honorable Ed Whitfield to the Subcommittee on Oversight and Investigations, December 13, 2005. Safety of Imported Pharmaceuticals: Strengthening Efforts to Combat Sales of Controlled Substances Over the Internet, Washington, DC: Committee on Energy and Commerce, 2005(available at: http://energycommerce.house.gov/reparchives/108/Hearings/12132005hearing...).
-
- Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Depend. 2006;81:103–107. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
